{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:28:34Z","timestamp":1760549314128},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T00:00:00Z","timestamp":1344211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-180","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T08:15:12Z","timestamp":1352708112000},"source":"Crossref","is-referenced-by-count":16,"title":["Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance"],"prefix":"10.1186","volume":"12","author":[{"given":"Paula","family":"Freitas","sequence":"first","affiliation":[]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Ana Cristina","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Mesquita","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Matos","sequence":"additional","affiliation":[]},{"given":"Antonio Jose","family":"Madureira","sequence":"additional","affiliation":[]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Lu\u00eds","family":"Medina","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,6]]},"reference":[{"issue":"13","key":"2022_CR1","first-page":"853","volume":"338","author":"FJ Palella","year":"1998","unstructured":"Palella FJ: Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ. Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998, 338 (13): 853-860.","journal-title":"Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med"},{"issue":"5","key":"2022_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/QAI.0b013e31819c291b","volume":"50","author":"K Samaras","year":"2009","unstructured":"Samaras K: Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr. 2009, 50 (5): 499-505. 10.1097\/QAI.0b013e31819c291b.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2022_CR3","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","volume":"16","author":"MA Noor","year":"2002","unstructured":"Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C: Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002, 16 (5): F1-8. 10.1097\/00002030-200203290-00002.","journal-title":"AIDS"},{"issue":"5","key":"2022_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1086\/505974","volume":"43","author":"GA Lee","year":"2006","unstructured":"Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C: Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis. 2006, 43 (5): 658-660. 10.1086\/505974.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2022_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2337\/dc07-2013","volume":"31","author":"S De Wit","year":"2008","unstructured":"De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Moller N, Phillips A: Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008, 31 (6): 1224-1229. 10.2337\/dc07-2013.","journal-title":"Diabetes Care"},{"issue":"13","key":"2022_CR6","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","volume":"19","author":"TT Brown","year":"2005","unstructured":"Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS: Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS. 2005, 19 (13): 1375-1383. 10.1097\/01.aids.0000181011.62385.91.","journal-title":"AIDS"},{"issue":"6","key":"2022_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.108.790857","volume":"119","author":"SW Worm","year":"2009","unstructured":"Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Moller N: Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation. 2009, 119 (6): 805-811. 10.1161\/CIRCULATIONAHA.108.790857.","journal-title":"Circulation"},{"issue":"8","key":"2022_CR8","first-page":"1179","volume":"17","author":"N Friis-Moller","year":"2003","unstructured":"Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O: d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD: Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study. AIDS. 2003, 17 (8): 1179-1193.","journal-title":"Results from the DAD study. AIDS"},{"issue":"6","key":"2022_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1468-1293.2006.00400.x","volume":"7","author":"TR Glass","year":"2006","unstructured":"Glass TR, Ungsedhapand C, Wolbers M, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC: Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med. 2006, 7 (6): 404-410. 10.1111\/j.1468-1293.2006.00400.x.","journal-title":"HIV Med"},{"issue":"10","key":"2022_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1258\/095646205774357398","volume":"16","author":"J Santos","year":"2005","unstructured":"Santos J, Palacios R, Gonzalez M, Ruiz J, Marquez M: Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Netar Study). Int J STD AIDS. 2005, 16 (10): 677-680. 10.1258\/095646205774357398.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.107.189622","volume":"118","author":"SK Grinspoon","year":"2008","unstructured":"Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dube MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH: State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS: executive summary. Circulation. 2008, 118 (2): 198-210. 10.1161\/CIRCULATIONAHA.107.189622.","journal-title":"Circulation"},{"issue":"1","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1086\/317541","volume":"32","author":"C Hadigan","year":"2001","unstructured":"Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D'Agostino RB, Grinspoon S: Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001, 32 (1): 130-139. 10.1086\/317541.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","volume":"33","author":"JS Currier","year":"2003","unstructured":"Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S: Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003, 33 (4): 506-512. 10.1097\/00126334-200308010-00012.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9119","key":"2022_CR14","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA: Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998, 351 (9119): 1881-1883. 10.1016\/S0140-6736(98)03391-1.","journal-title":"Lancet"},{"issue":"16","key":"2022_CR15","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","volume":"15","author":"M van der Valk","year":"2001","unstructured":"van der Valk M, Bisschop PH, Romijn JA, Ackermans MT, Lange JM, Endert E, Reiss P, Sauerwein HP: Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS. 2001, 15 (16): 2093-2100. 10.1097\/00002030-200111090-00004.","journal-title":"AIDS"},{"key":"2022_CR16","unstructured":"Human immunodeficiency virus (HIV) infection codes and new codes for Kaposi's sarcoma. MMWR Recomm Rep. 1991, 40 (RR-9): 1-18."},{"issue":"2","key":"2022_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jocd.2010.01.005","volume":"13","author":"P Freitas","year":"2010","unstructured":"Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL: Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy. J Clin Densitom. 2010, 13 (2): 197-203. 10.1016\/j.jocd.2010.01.005.","journal-title":"J Clin Densitom"},{"key":"2022_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1471-2334-11-246","volume":"11","author":"P Freitas","year":"2011","unstructured":"Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011, 11: 246-10.1186\/1471-2334-11-246.","journal-title":"BMC Infect Dis"},{"key":"2022_CR19","volume-title":"J Endocrinol Invest","author":"P Freitas","year":"2011","unstructured":"Freitas P, Carvalho D, Santos AC, Mesquita J, Correia F, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults. J Endocrinol Invest. 2011"},{"key":"2022_CR20","first-page":"AA","volume":"AA","author":"P Freitas","year":"2011","unstructured":"Freitas P, Carvalho D, Santos AC, Matos MJ, Madureira AJ, Marques R, Martinez E, Sarmento A, Medina JL: Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy. J Endocrinol Invest. 2011, AA: AA-AA.","journal-title":"J Endocrinol Invest"},{"issue":"16","key":"2022_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"issue":"3","key":"2022_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1385\/JCD:8:3:287","volume":"8","author":"E Bonnet","year":"2005","unstructured":"Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J: Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005, 8 (3): 287-292. 10.1385\/JCD:8:3:287.","journal-title":"J Clin Densitom"},{"issue":"4","key":"2022_CR23","first-page":"187","volume":"17","author":"K van der Kooy","year":"1993","unstructured":"van der Kooy K, Seidell JC: Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993, 17 (4): 187-196.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"2022_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","volume":"211","author":"T Yoshizumi","year":"1999","unstructured":"Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 1999, 211 (1): 283-286.","journal-title":"Radiology"},{"key":"2022_CR25","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care. 2009, 32 (Suppl 1): S62-S67.","DOI":"10.2337\/dc09-S062"},{"issue":"7","key":"2022_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"7","key":"2022_CR27","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85 (7): 2402-2410. 10.1210\/jc.85.7.2402.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2022_CR28","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999, 22 (9): 1462-1470. 10.2337\/diacare.22.9.1462.","journal-title":"Diabetes Care"},{"issue":"10","key":"2022_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","volume":"47","author":"E Bonora","year":"1998","unstructured":"Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998, 47 (10): 1643-1649. 10.2337\/diabetes.47.10.1643.","journal-title":"Diabetes"},{"issue":"10","key":"2022_CR30","first-page":"1138","volume":"19","author":"SM Haffner","year":"1996","unstructured":"Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H: A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996, 19 (10): 1138-1141.","journal-title":"The Mexico City Diabetes Study. Diabetes Care"},{"key":"2022_CR31","volume-title":"J Clin Densitom","author":"P Freitas","year":"2010","unstructured":"Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL: Fat Mass Ratio: An Objective Tool to Define Lipodystrophy in HIV-Infected Patients Under Antiretroviral Therapy. J Clin Densitom. 2010"},{"issue":"4","key":"2022_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","volume":"39","author":"KA Lichtenstein","year":"2005","unstructured":"Lichtenstein KA: Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr. 2005, 39 (4): 395-400. 10.1097\/01.qai.0000167478.28051.3a.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2022_CR33","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979, 237 (3): E214-223.","journal-title":"Am J Physiol"},{"key":"2022_CR34","first-page":"97","volume":"3","author":"HPH Carlos Lorenzo","year":"2012","unstructured":"Carlos Lorenzo HPH, Haffner SM: Insulin Resistance and Excess Risk of Diabetes in Mexican-Americans: The San Antonio Heart Study. J Clin Endocrinol Metab. 2012, 3: 97-","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2022_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/QAI.0b013e31814b94e2","volume":"46","author":"C Grunfeld","year":"2007","unstructured":"Grunfeld C, Rimland D, Gibert CL, Powderly WG, Sidney S, Shlipak MG, Bacchetti P, Scherzer R, Haffner S, Heymsfield SB: Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr. 2007, 46 (3): 283-290. 10.1097\/QAI.0b013e31814b94e2.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2022_CR36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/76.2.460","volume":"76","author":"G Meininger","year":"2002","unstructured":"Meininger G, Hadigan C, Rietschel P, Grinspoon S: Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men. Am J Clin Nutr. 2002, 76 (2): 460-465.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"2022_CR37","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","volume":"51","author":"SK Gan","year":"2002","unstructured":"Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, Cooper DA, Chisholm DJ: Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes. 2002, 51 (11): 3163-3169. 10.2337\/diabetes.51.11.3163.","journal-title":"Diabetes"},{"issue":"4","key":"2022_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","volume":"25","author":"DC Mynarcik","year":"2000","unstructured":"Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC: Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr. 2000, 25 (4): 312-321. 10.1097\/00126334-200012010-00004.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2022_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/QAI.0b013e318031d7e3","volume":"45","author":"I Brar","year":"2007","unstructured":"Brar I, Shuter J, Thomas A, Daniels E, Absalon J: A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr. 2007, 45 (1): 66-71. 10.1097\/QAI.0b013e318031d7e3.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"2022_CR40","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","volume":"165","author":"TT Brown","year":"2005","unstructured":"Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS: Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005, 165 (10): 1179-1184. 10.1001\/archinte.165.10.1179.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2022_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/hep.20289","volume":"40","author":"AA Butt","year":"2004","unstructured":"Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC: Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology. 2004, 40 (1): 115-119. 10.1002\/hep.20289.","journal-title":"Hepatology"},{"issue":"10","key":"2022_CR42","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1086\/429824","volume":"40","author":"AA Howard","year":"2005","unstructured":"Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, Schoenbaum EE: Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005, 40 (10): 1492-1499. 10.1086\/429824.","journal-title":"Clin Infect Dis"},{"issue":"9170","key":"2022_CR43","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999, 353 (9170): 2093-2099. 10.1016\/S0140-6736(98)08468-2.","journal-title":"Lancet"},{"issue":"7","key":"2022_CR44","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998, 12 (7): F51-58. 10.1097\/00002030-199807000-00003.","journal-title":"AIDS"},{"issue":"9359","key":"2022_CR45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG: An objective case definition of lipodystrophy in HIV-infected adults: a case\u2013control study. Lancet. 2003, 361 (9359): 726-735. 10.1016\/S0140-6736(03)12656-6.","journal-title":"Lancet"},{"issue":"13","key":"2022_CR46","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","volume":"21","author":"PC Tien","year":"2007","unstructured":"Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE: Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS. 2007, 21 (13): 1739-1745. 10.1097\/QAD.0b013e32827038d0.","journal-title":"AIDS"},{"issue":"10","key":"2022_CR47","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/QAD.0b013e32832bd7af","volume":"23","author":"AA Butt","year":"2009","unstructured":"Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz MB, Leaf D, Justice AC: HIV infection and the risk of diabetes mellitus. AIDS. 2009, 23 (10): 1227-1234. 10.1097\/QAD.0b013e32832bd7af.","journal-title":"AIDS"},{"issue":"1","key":"2022_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","volume":"23","author":"K Mulligan","year":"2000","unstructured":"Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M: Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000, 23 (1): 35-43.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"2022_CR49","doi-asserted-by":"publisher","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","volume":"13","author":"G Behrens","year":"1999","unstructured":"Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Korner T, Stoll M, Schmidt RE: Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS. 1999, 13 (10): F63-70. 10.1097\/00002030-199907090-00001.","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-180\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:30:15Z","timestamp":1548203415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-180","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,6]]},"article-number":"180"}}